AKT1 and prostate cancer: Treatment of LNCaP cells with FQ (30 μM) for 2 h in the presence or absence of serum in culture media resulted in a striking decrease in phosphorylated Akt levels, suggesting that FQ acts as Akt inhibitor in prostate cancer cells (Fig. 2G).